| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035767A1 Reagent kit for cultivating cells |
| 04/29/2004 | WO2004035766A2 In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor |
| 04/29/2004 | WO2004035761A2 Bone marrow cell differentiation |
| 04/29/2004 | WO2004035758A2 Rna-based inhibitory oligonucleotides |
| 04/29/2004 | WO2004035748A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | WO2004035628A1 Regulation o-if the cre recombinase using a dissociation/re association system of said recombinase |
| 04/29/2004 | WO2004035619A1 Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments |
| 04/29/2004 | WO2004035609A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 04/29/2004 | WO2004035607A2 Human monoclonal antibodies against cd20 |
| 04/29/2004 | WO2004035537A2 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 04/29/2004 | WO2004035102A1 Method of replacing human soft tissue volume by in vitro culturing human preadipocyte in injectable material |
| 04/29/2004 | WO2004035101A1 Support for tissue regeneration and process for producing the same |
| 04/29/2004 | WO2004035082A2 Proteins involved in the regulation of energy homeostasis |
| 04/29/2004 | WO2004035006A2 Methods and compositions for immunization against hiv |
| 04/29/2004 | WO2004034984A2 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 04/29/2004 | WO2004034966A2 Substances for preventing and treating autoimmune diseases |
| 04/29/2004 | WO2004034890A2 Biological scaffolding material |
| 04/29/2004 | WO2004034887A2 Compositions, solutions, and methods used for transplantation |
| 04/29/2004 | WO2004034789A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 04/29/2004 | WO2004020606A9 Method of resisting osteoclast formation |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004015107A3 Further novel forms of interfering rna molecules |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004013275A3 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 04/29/2004 | WO2004011630A3 Biomimetic urothelium |
| 04/29/2004 | WO2004005470A3 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2004000993A3 Oxytocin as cardiomyogenesis inducer and uses thereof |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003075840A3 Human antibodies specific to kdr and uses thereof |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003064601A8 Adult human olfactory stem cell |
| 04/29/2004 | WO2003064496A9 Biodegradable polymer |
| 04/29/2004 | WO2003063575A8 Endothelialization of vascular surfaces |
| 04/29/2004 | WO2003060147A3 Method of obtaining purified enterochromaffin cells and methods of using same |
| 04/29/2004 | WO2003060087A3 Rapid method of selecting cells for gene disruption by homologous recombination |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003032913A9 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | WO2003015612A9 Materials and methods to promote repair of nerve tissue |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002068599A3 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 04/29/2004 | WO2002046372A9 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 04/29/2004 | WO2002043651A8 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | US20040083498 Cloning method using oocytes matured in vivo |
| 04/29/2004 | US20040082773 Modified PAR receptors, their preparation and their uses for selecting compounds which modulate PAR activity |
| 04/29/2004 | US20040082763 Diagnosis, therapy of Alzheimer's disease; synthetic antibody |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082535 Glucocerebrosidas DNA molecule having modification in one nucleotide that disrupts splicing consensus sequence and prevents splicing of mRNA produced from DNA molecule, while preserving ability of DNA to express glucocerebrosidas enzyme |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082522 Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease |
| 04/29/2004 | US20040082513 Enzyme-mediated modification of fibrin for tissue engineering |
| 04/29/2004 | US20040082066 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 04/29/2004 | US20040082065 Cascading priming cells; stimulating lymphocytes; incubation |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040082063 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
| 04/29/2004 | US20040082062 Method and medium for in vitro culture of human embryos |
| 04/29/2004 | US20040082017 Protein for drug screening; purification of lysosomes; fusion protein; nucleotide sequence coding polypeptide; quantitative analysis |
| 04/29/2004 | US20040082012 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 04/29/2004 | US20040082003 Stem cell expansion enhancing factor and method of use |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040082000 Identification of genetic components of drug response |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081982 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2502552A1 Human monoclonal antibodies against cd20 |
| 04/29/2004 | CA2502367A1 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2502250A1 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | CA2501994A1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/29/2004 | CA2497806A1 Support for tissue regeneration and process for producing the same |
| 04/28/2004 | EP1413625A1 Composition for biological medium comprising sodium erythorbate |
| 04/28/2004 | EP1413587A2 Modified complement system regulator |
| 04/28/2004 | EP1413586A1 Regulation of the Cre recombinase using a dissociation/re-association system of said recombinase |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412750A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412747A1 Method and means for detecting alcohol consumption |
| 04/28/2004 | EP1412538A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 04/28/2004 | EP1412509A2 Rna amplification system using plant components in animal cells |
| 04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
| 04/28/2004 | EP1412503A2 A fusion protein |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412493A2 Methods and compositions relating to improved lentiviral vector production systems |